References
- MacDonald D, Aguiar R CT, Mason P J, Goldman J M, Cross N CP. A new myeloproliferative disorder associated with chromosome translocation involving 8p11: a review. Leukemia 1995; 10: 1628–1630
- Inhorn R C, Aster J C, Roach S A, Slapak C A, Soiffer R, Tantravahi R, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood 1995; 85: 1881–1887
- Macdonald D, Reiter A, Cross N CP. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002; 107: 101–107
- Belloni E, Trubia M, Gasparini P, Micucci C, Tapinassi C, Confalonieri S, et al. 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes. Genes Chromosomes Cancer 2005; 42: 320–325
- Grand E K, Grand F H, Chase A J, Ross F M, Corcoran M M, Oscier D G, et al. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 2004; 40: 78–83
- Hidalgo-Curtis C, Chase A, Drachenberg M, Roberts M W, Finkelstein J Z, Mould S, et al. The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes Chromosomes Cancer 2008; 47: 379–385
- Walz C, Chase A, Schoch C, Weisser A, Schlegel F, Hochhaus A, et al. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1. Leukemia 2005; 19: 1005–1009
- Guasch G, Popovici C, Mugneret F, Chaffanet M, Pontarotti P, Birnbaum D, et al. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood 2003; 101: 286–288
- Macdonald D, Cross N C. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy. Pathobiology 2007; 74: 81–88
- Vannier J P, Bizet M, Bastard A, Ducastelle T, Tron P. Simultaneous occurrence of a T-cell lymphoma and a chronic myelogenous leukaemia with an unusual karyotype. Leuk Res 1984; 8: 647–657
- Elsner S, Martin H, Rode C, Wassmann B, Ganser A, Hoelzer D. An uncommon translocation t(6;8) associated with atypical acute myeloid leukaemia myeloproliferative disease detected by fluorescence in-situ hybridization. Br J Haematol 1994; 87(Suppl 1)124
- Chaffanet M, Popovici C, Leroux D, Jacrot M, Adelaide J, Dastugue N, et al. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11‐12. Oncogene 1998; 16: 945–949
- Sohal J, Chase A, Mould S, Corcoran M, Oscier D, Iqbal S, et al. Identification of four new translocations involving FGFRI in myeloid disorders. Genes Chromosomes Cancer 2001; 32: 155–163
- Popovici C, Zhang B, Gregoire M J, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D, et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood 1999; 93: 1381–1389
- Vizmanos J L, Hernández R, Vidal M J, Larráyoz M J, Odero M D, Marin J, et al. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases. Hematol J 2004; 5: 534–537
- Tefferi A, Vardiman J W. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14–22
- Pierre R, Imbert M, Thiele J. Polycythaemia vera. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC Press, Lyon 2001; 32–34
- Monte-Mór B CR, Cunha A F, Pagnano K BB, Saad S TO, Lorand-Metze I, Costa F F. JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia. Genetics Mol Biol 2007; 30: 336–338